Takeda launches pharmaceutical company with PE partner & more: 4 GI company key notes

Here are four updates on gastroenterology companies from the past week:

Takeda and Frazier Healthcare Partners launched Phathom Pharmaceuticals to develop gastrointestinal treatments.

The FDA accepted Takeda's application for an injectable version of its ulcerative colitis drug Entyvio.

Virgo Surgical Video Solutions celebrated two milestones when it received a patent and surpassed 30,000 recordings with its automated video-recording platform.

Motus GI released its first quarter 2019 financial results, posting a $6.3 million net loss, or a $0.29 loss per diluted share. Read more.

More articles on gastroenterology: 
CHI Franciscan to divest ASC, pay $2.5M to settle anticompetitive lawsuit: 5 things to know
Surgery Partners reports $417M in revenue & more — 10 ASC industry notes
As investors favor ASCs & offices, major skilled nursing operator splits segments

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months